why am i not losing weight on retatrutide Results: How Much Can You Lose & How Quick? VisualAbstract: Retatrutide reduces body weight

In the STEP 1 semaglutide trial (Wilding et al., NEJM , 2021) and the SURMOUNT-1 tirzepatide trial (Jastreboff et al., NEJM , 2022), nausea affected roughly 44% of semaglutide patients and about 24% of tirzepatide patients at the maximum dose

Safety & Side Effects Profile similar to incretin therapies, with GI effects predominant (nausea, vomiting, diarrhea, constipation)often during escalation and improving over time

After speaking with the company and observing recent customer feedback, including a significant upward trend in their TrustPilot score, we believe they have stabilized their pharmacy operations and service levels

doi: 10.1111/j.1463-1326.2007.00733.x